Proteomics International Laboratories has signed a licence agreement to sell its PromarkerD predictive test for diabetic kidney disease in Chile, expanding its reach into the Central and South American markets.
Proteomics International Laboratories Ltd is pleased to announce the signing of a licence agreement to expand PromarkerD s reach in Central and South America. The deal with long-standing partner.
Proteomics International Laboratories Ltd is pleased to release a copy of the Chairman s Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman s Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to shareholders.